These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 18006488)
1. Disruption of calcium homeostasis and arrhythmogenesis induced by mutations in the cardiac ryanodine receptor and calsequestrin. Liu N; Priori SG Cardiovasc Res; 2008 Jan; 77(2):293-301. PubMed ID: 18006488 [TBL] [Abstract][Full Text] [Related]
2. Catecholaminergic polymorphic ventricular tachycardia from bedside to bench and beyond. Katz G; Arad M; Eldar M Curr Probl Cardiol; 2009 Jan; 34(1):9-43. PubMed ID: 19068246 [TBL] [Abstract][Full Text] [Related]
3. Inherited dysfunction of sarcoplasmic reticulum Ca2+ handling and arrhythmogenesis. Priori SG; Chen SR Circ Res; 2011 Apr; 108(7):871-83. PubMed ID: 21454795 [TBL] [Abstract][Full Text] [Related]
4. Molecular and tissue mechanisms of catecholaminergic polymorphic ventricular tachycardia. Wleklinski MJ; Kannankeril PJ; Knollmann BC J Physiol; 2020 Jul; 598(14):2817-2834. PubMed ID: 32115705 [TBL] [Abstract][Full Text] [Related]
11. A case of catecholaminergic polymorphic ventricular tachycardia caused by two calsequestrin 2 mutations. de la Fuente S; Van Langen IM; Postma AV; Bikker H; Meijer A Pacing Clin Electrophysiol; 2008 Jul; 31(7):916-9. PubMed ID: 18684293 [TBL] [Abstract][Full Text] [Related]
12. Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia. Song L; Alcalai R; Arad M; Wolf CM; Toka O; Conner DA; Berul CI; Eldar M; Seidman CE; Seidman JG J Clin Invest; 2007 Jul; 117(7):1814-23. PubMed ID: 17607358 [TBL] [Abstract][Full Text] [Related]
13. Abnormal interactions of calsequestrin with the ryanodine receptor calcium release channel complex linked to exercise-induced sudden cardiac death. Terentyev D; Nori A; Santoro M; Viatchenko-Karpinski S; Kubalova Z; Gyorke I; Terentyeva R; Vedamoorthyrao S; Blom NA; Valle G; Napolitano C; Williams SC; Volpe P; Priori SG; Gyorke S Circ Res; 2006 May; 98(9):1151-8. PubMed ID: 16601229 [TBL] [Abstract][Full Text] [Related]
14. Prevention of ventricular arrhythmia and calcium dysregulation in a catecholaminergic polymorphic ventricular tachycardia mouse model carrying calsequestrin-2 mutation. Alcalai R; Wakimoto H; Arad M; Planer D; Konno T; Wang L; Seidman JG; Seidman CE; Berul CI J Cardiovasc Electrophysiol; 2011 Mar; 22(3):316-24. PubMed ID: 20807279 [TBL] [Abstract][Full Text] [Related]